vimarsana.com

Latest Breaking News On - Nasdaq sbcf - Page 6 : vimarsana.com

Aptus Capital Advisors LLC Grows Stake in Seacoast Banking Co of Florida (NASDAQ:SBCF)

Aptus Capital Advisors LLC increased its stake in Seacoast Banking Co. of Florida (NASDAQ:SBCF – Free Report) by 14.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 145,400 shares of the financial services provider’s stock after acquiring an […]

Truist Financial Boosts Seacoast Banking Co of Florida (NASDAQ:SBCF) Price Target to $28 00

Seacoast Banking Co. of Florida (NASDAQ:SBCF – Free Report) had its price target boosted by Truist Financial from $25.00 to $28.00 in a research note published on Tuesday, MarketBeat Ratings reports. They currently have a buy rating on the financial services provider’s stock. Several other equities research analysts have also recently weighed in on SBCF. […]

Seacoast Banking Co of Florida (NASDAQ:SBCF) PT Raised to $27 00

Seacoast Banking Co. of Florida (NASDAQ:SBCF – Free Report) had its target price hoisted by Raymond James from $26.00 to $27.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have an outperform rating on the financial services provider’s stock. SBCF has been the topic of a number of other […]

Raymond James Raises Seacoast Banking Co of Florida (NASDAQ:SBCF) Price Target to $27 00

Seacoast Banking Co. of Florida (NASDAQ:SBCF – Free Report) had its price objective hoisted by Raymond James from $26.00 to $27.00 in a research report released on Monday morning, Benzinga reports. The firm currently has an outperform rating on the financial services provider’s stock. A number of other brokerages have also recently issued reports on […]

Seacoast Banking Corporation of Florida (SBCF) Stock: A Closer Look at the Market Potential

The price-to-earnings ratio for Seacoast Banking Corporation of Florida (NASDAQ: SBCF) is above average at 18.00x, while the 36-month beta value is 1.12.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,&#

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.